Finally, the SEPT9 methylation test originally developed for plasma detection of colorectal cancer has been applied to lung cancer, and correctly identified 31/70 (44%) of lung cancer samples, while only giving a positive signal in 4/100 controls (Powrozek et al., 2014). This evidence concerns the gene SEPTIN9 and lung carcinoma.